Source:http://linkedlifedata.com/resource/pubmed/id/18098326
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-2-5
|
pubmed:abstractText |
We previously identified a small population of replicative hepatocytes in long-term cultures of human adult parenchymal hepatocytes (PHs) at a frequency of 0.01%-0.09%. These hepatocytes were able to grow continuously through serial subcultures as colony-forming parenchymal hepatocytes (CFPHs). In the present study, we generated gene expression profiles for cultured CFPHs and found that they expressed cytokeratin 19, CD90 (Thy-1), and CD44, but not mature hepatocyte markers such as tryptophan-2,3-dioxygenase (TO) and glucose-6-phosphatase (G6P), confirming that these cells are hepatic progenitor-like cells. The cultured CFPHs were resistant to infection with human hepatitis B virus (HBV). To examine the growth and differentiation capacity of the cells in vivo, serially subcultured CFPHs were transplanted into the progeny of a cross between albumin promoter/enhancer-driven urokinase plasminogen activator-transgenic mice and severe combined immunodeficient (SCID) mice. The cells were engrafted into the liver and were able to grow for at least 10 weeks, ultimately reaching a maximum occupancy rate of 27%. The CFPHs in the host liver expressed differentiation markers such as TO, G6P, and cytochrome P450 subtypes and could be infected with HBV. CFPH-chimeric mice with a relatively high replacement rate exhibited viremia and had high serum levels of hepatitis B surface antigen. CONCLUSION: Serially subcultured human hepatic progenitor-like cells from postnatal livers successfully repopulated injured livers and exhibited several phenotypes of mature hepatocytes, including susceptibility to HBV. In vitro-expanded CFPHs can be used to characterize the differentiation state of human hepatic progenitor-like cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1527-3350
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
435-46
|
pubmed:meshHeading |
pubmed-meshheading:18098326-Adolescent,
pubmed-meshheading:18098326-Animals,
pubmed-meshheading:18098326-Cells, Cultured,
pubmed-meshheading:18098326-Child,
pubmed-meshheading:18098326-Colony-Forming Units Assay,
pubmed-meshheading:18098326-Cryopreservation,
pubmed-meshheading:18098326-Female,
pubmed-meshheading:18098326-Gene Expression Profiling,
pubmed-meshheading:18098326-Hepatitis B virus,
pubmed-meshheading:18098326-Hepatocytes,
pubmed-meshheading:18098326-Humans,
pubmed-meshheading:18098326-Infant,
pubmed-meshheading:18098326-Male,
pubmed-meshheading:18098326-Mice,
pubmed-meshheading:18098326-Mice, SCID,
pubmed-meshheading:18098326-Mice, Transgenic,
pubmed-meshheading:18098326-Transplantation Chimera
|
pubmed:year |
2008
|
pubmed:articleTitle |
Susceptibility of chimeric mice with livers repopulated by serially subcultured human hepatocytes to hepatitis B virus.
|
pubmed:affiliation |
Yoshizato Project, Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER), Hiroshima Prefectural Institute of Industrial Science and Technology, Hiroshima, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|